Your browser doesn't support javascript.
loading
Optimal dose of dabigatran for the prevention of thromboembolism with minimal bleeding risk in Korean patients with atrial fibrillation.
Lee, Ki Hong; Park, Hyung Wook; Lee, Nuri; Hyun, Dae Young; Won, Jumin; Oh, Sung Sik; Park, Hyuk Jin; Kim, Yongcheol; Cho, Jae Yeong; Kim, Min Chul; Sim, Doo Sun; Yoon, Hyun Joo; Yoon, Nam Sik; Kim, Kye Hun; Hong, Young Joon; Kim, Ju Han; Ahn, Youngkeun; Jeong, Myung Ho; Park, Jong Chun; Cho, Jeong Gwan.
  • Lee KH; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Park HW; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Lee N; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Hyun DY; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Won J; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Oh SS; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Park HJ; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Kim Y; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Cho JY; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Kim MC; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Sim DS; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Yoon HJ; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Yoon NS; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Kim KH; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Hong YJ; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Kim JH; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Ahn Y; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Jeong MH; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Park JC; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
  • Cho JG; Cardiovascular Medicine, Chonnam National University Hospital, 42 Jaebong-ro, Dong-gu, Gwangju 61469, South Korea.
Europace ; 19(suppl_4): iv1-iv9, 2017 Dec 01.
Article en En | MEDLINE | ID: mdl-29220421

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Tromboembolia / Warfarina / Coagulación Sanguínea / Antitrombinas / Accidente Cerebrovascular / Dabigatrán / Hemorragia / Anticoagulantes Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 País como asunto: Asia Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Tromboembolia / Warfarina / Coagulación Sanguínea / Antitrombinas / Accidente Cerebrovascular / Dabigatrán / Hemorragia / Anticoagulantes Tipo de estudio: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged80 País como asunto: Asia Idioma: En Año: 2017 Tipo del documento: Article